ICI 204,636: A new atypical antipsychotic drug

被引：43

作者：

Hirsch, SR

Link, CGG

Goldstein, JM

Arvanitis, LA

机构：

[1] ZENECA PHARMACEUT,MACCLESFIELD,CHESHIRE,ENGLAND

[2] ZENECA PHARMACEUT,CNS CLIN RES,WILMINGTON,DE

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1996年 / 168卷

关键词：

D O I：

10.1192/S0007125000298310

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：45 / 56

页数：12

共 27 条

[1] CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES [J].

ALVIR, JMJ ;

LIEBERMAN, JA ;

SAFFERMAN, AZ ;

SCHWIMMER, JL ;

SCHAAF, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :162-167

[2]

ARVANITIS LA, 1995, SYLL P 148 ANN M AM

[3]

BLOOM FE, 1994, PSYCHOPHARMACOLOGY 4

[4] ICI 204,636, an atypical antipsychotic: Efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia [J].

Borison, RL ;

Arvanitis, LA ;

Miller, BG ;

Alphs, LD ;

Carman, JS ;

Diamond, B ;

Gewirtz, G ;

Hamner, MB ;

Hirshfield, R ;

McEvoy, JP ;

Mukherjee, S ;

Nasrallah, HA ;

Oxenkrug, G ;

Ryan, W ;

Smith, N ;

Tamminga, C .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1996, 16 (02) :158-169

[5] SEROQUEL (ICI-204,636) - A NOVEL, ATYPICAL ANTIPSYCHOTIC [J].

BORISON, RL ;

ARVANITIS, LA ;

MILLER, BG ;

LINK, CGG ;

HONG, WW .

BIOLOGICAL PSYCHIATRY, 1995, 37 (09) :661-661

[6] ICI-204,636, A NOVEL, ATYPICAL ANTIPSYCHOTIC - EARLY INDICATION OF SAFETY AND EFFICACY IN PATIENTS WITH CHRONIC AND SUBCHRONIC SCHIZOPHRENIA [J].

FABRE, LF ;

ARVANITIS, L ;

PULTZ, J ;

JONES, VM ;

MALICK, JB ;

SLOTNICK, VB .

CLINICAL THERAPEUTICS, 1995, 17 (03) :366-378

[7]

GOLDSTEIN J, 1995, 148TH ANN M AM PSYCH

[8] SEROQUEL - ELECTROPHYSIOLOGICAL PROFILE OF A POTENTIAL ATYPICAL ANTIPSYCHOTIC [J].

GOLDSTEIN, JM ;

LITWIN, LC ;

SUTTON, EB ;

MALICK, JB .

PSYCHOPHARMACOLOGY, 1993, 112 (2-3) :293-298

[9] EFFECTS OF SEROQUEL(R) AND OTHER ATYPICAL ANTIPSYCHOTICS IN PRIMATE MODELS OF EPS [J].

GOLDSTEIN, JM ;

SNYDER, DH .

BIOLOGICAL PSYCHIATRY, 1995, 37 (09) :646-647

[10]

GOLDSTEIN JM, 1995, EXPERT OPINION INVES, V4, P291

← 1 2 3 →